Results 71 to 80 of about 198,351 (337)

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Background Thrombopoietin receptor agonists (TPO‐RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count.
Adam Cuker   +13 more
doaj   +1 more source

What is new in the management of rapidly progressive glomerulonephritis? [PDF]

open access: yes, 2015
Rapidly progressive glomerulonephritis (RPGN) results from severe crescentic damage to glomeruli and leads to irreversible kidney failure if not diagnosed and managed in a timely fashion.
Greenhall, GHB, Salama, AD
core   +1 more source

Expansion Microscopy of Synaptic Contacts on the Mauthner Cells of Larval Zebrafish

open access: yesBio-Protocol
Because of its genetic tractability and amenability for live imaging, larval zebrafish (Danio rerio) have emerged as a model to study the cellular and synaptic properties underlying behavior.
Sundas Ijaz   +2 more
doaj   +1 more source

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. [PDF]

open access: yes, 2018
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder which presents with isolated thrombocytopenia and risk of hemorrhage. While most children with ITP promptly recover with or without drug therapy, ITP is persistent or chronic in ...
Bennett, Carolyn M.   +23 more
core   +1 more source

Learning to predict: Neuronal signatures of auditory expectancy in human event-related potentials

open access: yesNeuroImage, 2021
Learning to anticipate future states of the world based on statistical regularities in the environment is a key component of perception and is vital for the survival of many organisms.
Yonatan I. Fishman   +2 more
doaj  

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

open access: yesJournal of Thrombosis and Haemostasis, 2019
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life‐threatening autoimmune thrombotic microangiopathy. Caplacizumab, an anti‐von Willebrand Factor Nanobody®, is effective for treating aTTP episodes and is well tolerated.
P. Knoebl   +11 more
semanticscholar   +1 more source

A companion to the preclinical common data elements for rigor, reproducibility and transparency in basic and translational epilepsy research. A report of the TASK3‐WG1A: Pharmacology Working Group of the ILAE/AES Joint Translational Task Force

open access: yesEpilepsia Open, EarlyView.
Abstract Rigorous and transparent procedures in preclinical epilepsy research studies are important to permit assessing the reproducibility of their findings and derisk their translation into the clinic. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3‐WG1A) developed common data elements (CDEs) addressing rigor and transparency
Brian D. Klein   +11 more
wiley   +1 more source

The components of an electrical synapse as revealed by expansion microscopy of a single synaptic contact

open access: yeseLife
Most nervous systems combine both transmitter-mediated and direct cell–cell communication, known as ‘chemical’ and ‘electrical’ synapses, respectively. Chemical synapses can be identified by their multiple structural components.
Sandra P Cárdenas-García   +2 more
doaj   +1 more source

Proteostasis and RNA Binding Proteins in Synaptic Plasticity and in the Pathogenesis of Neuropsychiatric Disorders

open access: yesNeural Plasticity, 2016
Decades of research have demonstrated that rapid alterations in protein abundance are required for synaptic plasticity, a cellular correlate for learning and memory.
Matthew E. Klein   +2 more
doaj   +1 more source

PURPURA HEMORRHAGICA [PDF]

open access: yesThe American Journal of the Medical Sciences, 1905
n ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy